# Traumatic Optic Neuropathy Treatment Trial (TONTT)

> **NCT01783847** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 117 (actual)

## Conditions studied

- Traumatic Optic Neuropathy

## Interventions

- **DRUG:** Recombinant human erythropoietin (EPO)
- **OTHER:** Observation
- **DRUG:** Methyl prednisolone

## Key facts

- **NCT ID:** NCT01783847
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-04
- **Final completion:** 2017-02
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2019-05-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783847, "Traumatic Optic Neuropathy Treatment Trial (TONTT)". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01783847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*